SCHEMBL6152233

SCHEMBL6152233

CN1C(=O)C2=C(c3cccc4c3ccc3ccccc34)N(C)C(=O)C2=C1c1cccc2c1ccc1ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 1/20 0.45
TDP1 Q9NUW8 2/20 0.45
POLB P06746 1/20 0.44
PAX8 Q06710 1/20 0.43
ALDH1A1 P00352 6/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 2/20 0.41
CYP2D6 P10635 2/20 0.41
USP2 O75604 2/20 0.41
TP53 P04637 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
SIRT1 Q96EB6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152442 0.92 POLB (0.47) POLBALDH1A1MEN1KMT2ACYP1A2
SCHEMBL2757065 0.89 POLB (0.41) TDP1POLBPAX8ALDH1A1MEN1
SCHEMBL12394337 0.89 POLB (0.45) POLBALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12394333 0.87 MEN1 (0.39) TDP1POLBALDH1A1MEN1KMT2A
SCHEMBL14620065 0.84 POLB (0.41) POLBALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12394321 0.84 PIM1 (0.43) POLBCYP2C9CYP2C19KDM4EGAA
SCHEMBL12394320 0.83 KDM4E (0.42) POLBALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12394328 0.83 PPARG (0.41) POLBCYP2C9CYP2C19HSD17B10
SCHEMBL12394330 0.83 POLB (0.41) TDP1POLBALDH1A1CYP2C9CYP2C19
SCHEMBL12394336 0.83 PPARG (0.44) POLBCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK HPRT1 1490/4885TDP1 2196/4885POLB 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.